CXCR4 and non-Hodgkin lymphoma: BKT140, a high‐affinity CXCR4 antagonist, can even effectively inhibit those NHL cells hidden in the bone marrow of an immunodeficient mouse model, directly cause apoptotic cell death and reduce the stroma‐induced rituximab resistance 56.